RRAGB — Ras-Related GTP Binding B

RRAGB — Ras-Related GTP Binding B

Introduction

RRAGB (Ras-Related GTP Binding B) encodes a member of the Rag GTPase family that plays a critical role in amino acid sensing and the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway. This pathway is a central regulator of cell growth, metabolism, and autophagy in all eukaryotic cells, including neurons. In the nervous system, RRAGB-mediated mTORC1 activation is essential for synaptic plasticity, protein synthesis, and neuronal homeostasis—processes that become dysregulated in neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD) [@dang_mtor_2015].

The Rag GTPase family consists of five members: RRAGA (RagA), RRAGB (RagB), RRAGC (RagC), and RRAGD (RagD), which form heterodimers to sense amino acid availability and regulate mTORC1 localization and activity. RRAGB specifically partners with RRAGA to form the RagA/B heterodimer, which is the dominant active form in most cell types [@sancak_rag_2008].

RRAGB — Ras-Related GTP Binding B

Introduction

RRAGB (Ras-Related GTP Binding B) encodes a member of the Rag GTPase family that plays a critical role in amino acid sensing and the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway. This pathway is a central regulator of cell growth, metabolism, and autophagy in all eukaryotic cells, including neurons. In the nervous system, RRAGB-mediated mTORC1 activation is essential for synaptic plasticity, protein synthesis, and neuronal homeostasis—processes that become dysregulated in neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD) [@dang_mtor_2015].

The Rag GTPase family consists of five members: RRAGA (RagA), RRAGB (RagB), RRAGC (RagC), and RRAGD (RagD), which form heterodimers to sense amino acid availability and regulate mTORC1 localization and activity. RRAGB specifically partners with RRAGA to form the RagA/B heterodimer, which is the dominant active form in most cell types [@sancak_rag_2008].

<div class="infobox infobox-gene">
<div class="infobox-header">Gene Information</div>
<div class="infobox-content">
Symbol: RRAGB
Full Name: Ras-Related GTP Binding B
Chromosomal Location: Xq12
NCBI Gene ID: [10671](https://www.ncbi.nlm.nih.gov/gene/10671)
OMIM: [300260](https://www.omim.org/entry/300260)
Ensembl ID: [ENSG00000147434](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000147434)
UniProt ID: [Q9NQQ5](https://www.uniprot.org/uniprot/Q9NQQ5)
Associated Diseases: Neurodegeneration, X-linked Intellectual Disability, Parkinson's Disease
</div>
</div>

Molecular Structure and Function

Protein Structure

RRAGB is a small GTP-binding protein (~313 amino acids) with the characteristic GTPase fold. Like other Rag GTPases, RRAGB lacks C-terminal prenylation motifs typical of many Ras family proteins, instead localizing to cellular membranes through interactions with other proteins. The protein contains:

• N-terminal domain: GTP/GDP binding domain with Switch I and Switch II regions that undergo conformational changes between active (GTP-bound) and inactive (GDP-bound) states
• GTPase domain: Catalyzes GTP hydrolysis, regulated by GAPs (GTPase-activating proteins) and GEFs (guanine nucleotide exchange factors)
• C-terminal region: Involved in heterodimer formation with RRAGA

Heterodimer Formation

RRAGB forms obligate heterodimers with RRAGA (RagA), creating the RagA/B complex that is functionally indistinguishable in most contexts. This heterodimer is the biologically active unit that interacts with the mTORC1 regulator complex. The interaction between RRAGA and RRAGB is highly stable and required for their proper cellular localization and function.

GTP/GDP Cycling

The RagA/B heterodimer cycles between active GTP-bound and inactive GDP-bound states based on cellular amino acid levels:

• Amino acid sufficiency: GATOR1 complex acts as a GAP for RagA/B, promoting GDP-bound (inactive) state under amino acid starvation. Conversely, the GATOR2 complex inhibits GATOR1, allowing RagA/B to remain GTP-bound (active) when amino acids are present.
• Guanine nucleotide exchange: The Ragulator complex, anchored to the lysosomal membrane, acts as a GEF for RagA/B, promoting the GTP-bound (active) state in response to amino acid presence.

Role in mTORC1 Signaling

Amino Acid Sensing

RRAGB is a central component of the amino acid sensing pathway that regulates mTORC1 [@efeyan_mtor_2012]:

This pathway ensures that mTORC1 activity is coupled to nutrient availability, allowing cells to coordinate growth and metabolism with environmental conditions.

mTORC1 Pathway Downstream Effects

Once activated, mTORC1 phosphorylates multiple downstream targets:

• S6K1 (p70 ribosomal protein S6 kinase 1): Promotes protein synthesis through ribosomal biogenesis and translation initiation
• 4E-BP1 (eIF4E-binding protein 1): Releases eIF4E to enable cap-dependent translation
• ULK1 (Unc-51 Like Autophagy Activating Kinase 1): Inhibits autophagy initiation
• TFEB (Transcription Factor EB): Phosphorylates and inhibits TFEB nuclear translocation

Role in Neuronal Function

Synaptic Plasticity

In neurons, mTORC1 signaling is crucial for synaptic plasticity—the ability of synapses to strengthen or weaken in response to activity [@schubert_neuronal_2023]:

• Local protein synthesis: mTORC1 regulates translation of synaptic proteins at dendritic spines
• Long-term potentiation (LTP): Required for the formation and maintenance of LTP, a cellular basis for learning and memory
• Long-term depression (LTD): Regulates protein synthesis-dependent LTD
• Spine morphology: Controls dendritic spine growth and plasticity

Autophagy Regulation

Autophagy is essential for neuronal health, as post-mitotic neurons cannot dilute damaged proteins and organelles through cell division. The RRAGB-mTORC1 pathway tightly controls autophagy:

• mTORC1 inhibition: Under nutrient starvation, reduced RRAGB activity leads to decreased mTORC1 signaling
• Autophagy initiation: Low mTORC1 activity releases inhibition of ULK1 complex, initiating autophagy
• Lysosomal function: RRAGB coordinates lysosomal function with autophagy flux
• Proteostasis: Proper autophagy maintains neuronal proteostasis, preventing accumulation of damaged proteins

Neuronal Protein Synthesis

Neurons have unique requirements for protein synthesis:

• Local translation: Dendrites and axons require localized protein synthesis independent of the cell body
• Synaptic plasticity: Activity-dependent translation at synapses is crucial for learning and memory
• Axonal regeneration: Protein synthesis in axons is required for regeneration after injury

Expression Pattern

Brain Expression

RRAGB is expressed throughout the brain with high levels in:

• Hippocampus: CA1-CA3 pyramidal neurons, dentate gyrus granule cells
• Cerebral cortex: Layer V pyramidal neurons
• Cerebellum: Purkinje cells, granule cells
• Striatum: Medium spiny neurons
• Substantia nigra: Dopaminergic neurons

Cellular Localization

In neurons, RRAGB shows both cytosolic and lysosomal localization:

• Lysosomal membrane: Primary site for amino acid sensing and mTORC1 recruitment
• Cytosolic: Pool available for heterodimer formation and trafficking
• Synaptic terminals: Local signaling at synapses

Disease Associations

Alzheimer's Disease

RRAGB and mTORC1 signaling are dysregulated in AD [@kim_mtor_2022]:

| Aspect | Finding | Implication |
|--------|---------|-------------|
| mTORC1 hyperactivation | Increased phosphorylation of S6K and 4E-BP1 in AD brains | Impaired autophagy, protein aggregate accumulation |
| Lysosomal dysfunction | Reduced lysosomal acidification in AD neurons | Impaired amino acid sensing and mTORC1 regulation |
| Synaptic mTORC1 | Dysregulated translation at synapses | Memory deficits |
| Autophagy impairment | Reduced autophagic flux | Accumulation of amyloid and tau aggregates |

The hyperactivation of mTORC1 in AD is paradoxically linked to impaired protein synthesis and synaptic dysfunction, as chronic mTORC1 activation leads to feedback inhibition and translational dysregulation.

Parkinson's Disease

RRAGB involvement in PD relates to several mechanisms:

Genes in the Rag GTPase pathway may modify PD risk, though direct RRAGB mutations in PD remain to be firmly established.

X-linked Intellectual Disability

Given RRAGB's location on the X chromosome (Xq12), mutations may contribute to X-linked neurodevelopmental disorders:

• Impaired synaptic plasticity
• Deficits in learning and memory
• Altered neuronal connectivity

Other Neurodegenerative Conditions

• Huntington's Disease: mTORC1 dysregulation contributes to mutant huntingtin toxicity
• Amyotrophic Lateral Sclerosis (ALS): Dysregulated autophagy and mTOR signaling
• Frontotemporal Dementia: Impaired lysosomal function and mTORC1 signaling

Signaling Pathway Interactions

Lysosomal Function

The RRAGB-mTORC1 pathway is intrinsically linked to lysosomal biology [@meng_lysosome_2020]:

• Amino acid sensing: Lysosomes are the primary amino acid sensing organelles
• Autophagy-lysosome pathway: mTORC1 coordinates autophagosome-lysosome fusion
• Nutrient recycling: Lysosomal degradation releases amino acids that can be sensed by RRAGB
• Cellular homeostasis: Lysosomal dysfunction is a common feature of neurodegeneration

Ragulator Complex

The Ragulator complex (LAMTOR1-5) is essential for RRAGB function:

• Lysosomal anchoring: Tethers Rag GTPases to lysosomal membranes
• GEF activity: Promotes RagA/B GTP loading in response to amino acids
• Structural scaffold: Provides platform for mTORC1 recruitment

GATOR Complex

The GATOR complex regulates RRAGB activity:

• GATOR1 (CASTOR complex): Acts as GAP for RagA/B, promoting inactive state under amino acid starvation
• GATOR2: Inhibits GATOR1, allowing RagA/B activation when amino acids are sufficient

Interaction with Other Pathways

• AMPK signaling: Energy sensing converges with amino acid sensing
• Insulin signaling: Cross-talk with PI3K-Akt pathway
• Wnt signaling: mTORC1 integrates with developmental pathways

Therapeutic Implications

Target Potential

Modulating RRAGB-mTORC1 signaling has therapeutic potential:

The RRAGB-mTORC1 pathway represents a promising therapeutic target for neurodegenerative diseases. Rapamycin and other mTOR inhibitors have shown neuroprotective effects in preclinical models of AD, PD, and ALS by restoring proper autophagy. However, chronic mTOR inhibition can have adverse effects, highlighting the need for more targeted approaches targeting the Rag GTPase pathway specifically. [@cancellesi2023]

Autophagy Enhancement Strategies

Given the central role of RRAGB-mTORC1 signaling in autophagy regulation, therapeutic strategies aimed at enhancing autophagy through this pathway show considerable promise. TFEB activators, mTORC1 inhibitors, and agents that promote Rag GTPase inactivation in a controlled manner could restore proper autophagic flux in neurodegenerative diseases. Natural compounds such as trehalose and rapamycin have been shown to enhance autophagy through mTORC1-independent mechanisms, providing alternative therapeutic approaches that may be particularly relevant for conditions where RRAGB-mTORC1 signaling is dysregulated. [@wang2018]

Small Molecule Modulators

Emerging strategies include developing small molecules that specifically modulate Rag GTPase activity or GATOR complex function. These approaches could allow for more precise control of mTORC1 signaling without the broad immunosuppression and metabolic side effects associated with direct mTOR inhibitors. The GATOR1 and GATOR2 complexes represent attractive targets, as they directly regulate RRAGB nucleotide state and thus mTORC1 activity. [@radhi2020]

Challenges in CNS Drug Development

Developing therapies targeting the RRAGB-mTORC1 axis for central nervous system diseases faces several significant challenges. The blood-brain barrier limits delivery of many therapeutic agents to neural tissues. Additionally, mTORC1 has essential functions throughout the body, so systemic modulation may cause metabolic dysregulation. Neuron-specific delivery systems and biased agonists that preferentially affect neuronal mTORC1 signaling are areas of active research. Timing of intervention is also critical, as mTORC1 dysregulation in established disease may require different treatment strategies than preventive approaches.

Research Directions

• Genetic models: Conditional knockout of RRAGB in neurons
• Chemical probes: Specific modulators of Rag GTPases
• Biomarkers: Markers of mTORC1 activity in patients
• Single-cell studies: Understanding RRAGB function in specific neuronal populations
• Patient-derived models: iPSC neurons carrying disease mutations

Pathway Interactions and Cross-Talk

The RRAGB-mTORC1 pathway does not operate in isolation but engages in extensive cross-talk with numerous other signaling networks critical for neuronal health and systemic metabolism.

PI3K/Akt Pathway

Growth factor signaling through PI3K/Akt activates mTORC1 through inhibition of TSC1/2, providing a convergence point for nutrient and growth factor signals. This pathway is particularly important in neuronal survival signaling, as neurotrophic factors like BDNF signal through PI3K/Akt to promote mTORC1 activity. In neurodegenerative diseases, impaired growth factor signaling contributes to reduced mTORC1 activity and disrupted synaptic plasticity. [@dang2015]

AMPK Pathway

Energy depletion activates AMPK, which inhibits mTORC1 through multiple mechanisms including TSC2 phosphorylation and direct Raptor phosphorylation. This provides an essential checkpoint ensuring that mTORC1 activity is only sustained when cellular energy levels are adequate. In neurons, AMPK activation during metabolic stress can lead to synaptic dysfunction through excessive autophagy induction, highlighting the importance of balanced signaling through both pathways.

Lysosomal Function

The Rag GTPases require lysosomal localization for their function, linking mTORC1 activation to lysosomal health and integrity. Lysosomal dysfunction, a common feature in neurodegenerative diseases, impairs RRAGB-mediated amino acid sensing and leads to dysregulated mTORC1 signaling. This creates a vicious cycle where lysosomal impairment disrupts nutrient sensing, causing further lysosomal dysfunction through impaired autophagy. [@awan2019]

Protein Aggregation Pathways

Dysregulated mTORC1 leads to impaired autophagy and accumulation of toxic protein aggregates, a common feature in neurodegenerative diseases including amyloid-beta in Alzheimer's disease, alpha-synuclein in Parkinson's disease, and mutant huntingtin in Huntington's disease. The RRAGB-mTORC1 pathway thus represents a nexus where multiple neurodegenerative disease processes converge.

Signaling Pathway Diagram

Evolutionary Conservation

The Rag GTPase family is evolutionarily conserved from yeast to humans, reflecting the fundamental importance of amino acid sensing in cellular biology. RRAGB and its paralogs emerged early in eukaryotic evolution, with orthologs present in all eukaryotic organisms examined. The basic mechanism of Rag GTPase-mediated mTORC1 activation has been conserved, though regulatory complexity has increased in multicellular organisms. In mammals, the expanded Rag GTPase family allows for tissue-specific regulation of mTORC1, with neuronal-specific expression patterns for certain family members.

Animal Models and Experimental Evidence

Genetic Mouse Models

Knockout mouse models of Rag GTPase components have provided crucial insights into RRAGB function. Whole-body deletion of RagA or RagB is embryonic lethal, indicating essential developmental functions. Neuron-specific deletions demonstrate the critical role of Rag GTPase signaling in neuronal development, synaptic formation, and survival. Conditional knockout models allow for temporal control of gene deletion, enabling study of RRAGB function in adult neurons and during disease progression.

Drosophila Models

Drosophila melanogaster provides a powerful genetic model for studying RRAGB orthologs. Fly mutants lacking Rag GTPase function show developmental arrest and impaired growth that can be rescued by human RRAGB expression, demonstrating functional conservation. Genetic screens in flies have identified novel regulators of the Rag GTPase-mTORC1 pathway that are relevant to mammalian neuronal function.

Cell Culture Studies

Primary neuronal cultures and induced pluripotent stem cell-derived neurons allow for detailed molecular studies of RRAGB function. These systems demonstrate that RRAGB is essential for activity-dependent protein synthesis at synapses and for the neuronal response to amino acid starvation. Patient-derived neurons carrying mutations in mTORC1 pathway genes show impaired RRAGB-dependent signaling, providing direct evidence for the pathway's role in human neurological disease.

Future Research Directions

Unresolved Questions

Several key questions about RRAGB function in neurons remain unanswered. How does RRAGB activity specifically regulate local translation at synapses versus global protein synthesis in the cell body? What are the tissue-specific regulators that modulate RRAGB function in different neuronal populations? How do disease-causing mutations in lysosomal proteins affect RRAGB-mediated nutrient sensing?

Emerging Technologies

Advanced techniques including proximity labeling proteomics, single-molecule imaging, and optogenetic control of signaling pathways are beginning to address these questions. These approaches will allow for more precise understanding of RRAGB function and may reveal novel therapeutic targets within the pathway.

Clinical Translation

The development of biomarkers for RRAGB-mTORC1 pathway activity in patients represents a critical need. PET tracers for mTORC1 activity, cerebrospinal fluid markers of autophagy flux, and genetic predictors of treatment response could enable personalized approaches to targeting this pathway in neurodegenerative diseases.

Disease Associations Table

| Disease | RRAGB Dysfunction | Mechanism |
|---------|-------------------|------------|
| Alzheimer's Disease | mTORC1 hyperactivation | Impaired autophagy, synaptic dysfunction |
| Parkinson's Disease | Lysosomal dysfunction | Alpha-synuclein accumulation |
| X-linked ID | Possible mutations | Impaired synaptic plasticity |
| Huntington's Disease | mTORC1 dysregulation | Mutant huntingtin toxicity |

Key Publications

Cross-Links

• [mTOR Signaling](/mechanisms/mtor-signaling-neurodegeneration)
• [Autophagy](/mechanisms/autophagy)
• [Lysosomal Function](/mechanisms/lysosomal-function)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Alzheimer's Disease](/diseases/alzheimer-disease)
• [Parkinson's Disease](/diseases/parkinson-disease)
• [RRAGA](/genes/rraga)
• [RRAGC](/genes/rragc)

See Also

• [Genes Index](/genes)
• [Mechanisms Index](/mechanisms)
• [Diseases Index](/diseases)
• [mTOR Inhibitors](/treatments/mtor-inhibitors)

External Links

• [NCBI Gene Database](https://www.ncbi.nlm.nih.gov/gene/10671)
• [UniProt - Q9NQQ5](https://www.uniprot.org/uniprot/Q9NQQ5)
• [Ensembl - ENSG00000147434](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000147434)
• [OMIM - 300260](https://www.omim.org/entry/300260)
• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving RRAGB — Ras-Related GTP Binding B discovered through SciDEX knowledge graph analysis: